Published in Am J Clin Pathol on August 01, 1976
Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells. Am J Pathol (1986) 1.04
Electron microscopic findings for diagnosis of breast lesions. Med Mol Morphol (2005) 0.87
The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium. Am J Pathol (1984) 0.81
Ultrastructural and immunocytochemical study of a case of invasive cribriform breast carcinoma. J Clin Pathol (1988) 0.80
Neurohypophysial-hormone-responsive cell line derived from a dimethylbenzanthracene-induced rat mammary tumour. Biochem J (1980) 0.80
The relationship of terminal duct hyperplasia to mammary carcinoma in 7,12-dimethylbenz(alpha)anthracene-treated LEW/Mai rats. Am J Pathol (1980) 0.80
Histochemical analysis of hyperplastic stomach of TGF-alpha transgenic mice. Dig Dis Sci (1997) 0.79
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol (1998) 9.32
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst (1994) 6.37
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol (1997) 6.35
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med (1989) 6.24
1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med (1975) 5.48
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer (1975) 4.12
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol (1998) 3.94
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer (1983) 3.94
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol (1990) 3.12
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst (1988) 3.09
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol (2001) 3.00
Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol (1990) 2.89
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst (1998) 2.85
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer (1977) 2.16
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst (2001) 2.12
Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer (1978) 2.10
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer (1978) 2.08
Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol (1989) 2.03
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med (1989) 1.99
The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol (1994) 1.94
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol (2001) 1.87
Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst (1988) 1.72
Trauma and the localization of tumor cells. Cancer (1967) 1.71
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer (1986) 1.70
Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure. Cancer (1984) 1.65
Estimation of mucosal mucin as an aid in the differentiation of Crohn's disease of the colon and chronic ulcerative colitis. Am J Clin Pathol (1967) 1.54
Tumor size and regional lymph node metastasis in colorectal cancer. A preliminary analysis from the NSABP clinical trials. Cancer (1983) 1.51
Experimental renal vein constriction. Its relation to renal lesions observed in human renal vein thrombosis and the nephrotic syndrome. Lab Invest (1968) 1.49
The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings. Cancer (1980) 1.48
Cytogenesis of schwannoma (neurilemoma), neurofibroma, dermatofibroma, and dermatofibrosarcoma as revealed by electron microscopy. Am J Clin Pathol (1968) 1.46
Evaluation of a humoral factor in liver regeneration utilizing liver transplants. Cancer Res (1971) 1.45
Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med (1981) 1.45
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer (1986) 1.35
A portal blood factor as the humoral agent in liver regeneration. Science (1971) 1.34
Barrier function of lymph node to tumor cells and erythrocytes. I. Normal nodes. Cancer (1967) 1.33
Effects of potassium deficiency on experimental renovascular hypertension. Lab Invest (1967) 1.33
Transmigration of lymph nodes by tumor cells. Science (1966) 1.32
A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer (1977) 1.30
Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol (1986) 1.28
Histologic grading of breast cancer. Pathol Annu (1980) 1.28
Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum Pathol (1977) 1.28
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. Am J Clin Pathol (1980) 1.25
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer. Cancer (1975) 1.22
Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol (1985) 1.22
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer (1984) 1.22
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. J Clin Oncol (1986) 1.17
Solid and mucinous varieties of so-called mammary carcinoid tumors. Am J Clin Pathol (1979) 1.16
Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer (1980) 1.13
Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation. Cancer (1983) 1.10
Lumpectomy margins and much more. Cancer (1997) 1.09
Cirrhotic (hepatic) lobular glomerulonephritis. Correlation of ultrastructural and clinical features. Am J Pathol (1968) 1.09
Ultrastructural studies in hypertension. IV. Toxemia of pregnancy. Am J Pathol (1969) 1.08
Dermatofibrosarcoma with metastases simulating Hodgkin's disease and reticulum cell sarcoma. Cancer (1966) 1.07
The ultrastructure of chordoma. Am J Clin Pathol (1970) 1.02
The relationship of depth of penetration and tumor size to the number of positive nodes in Dukes C colorectal cancer. Cancer (1984) 1.02
The interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg Gynecol Obstet (1966) 1.02
Pathologic findings from the national surgical adjuvant breast project. (Protocol no. 4). III. The significance of extranodal extension of axillary metastases. Am J Clin Pathol (1976) 1.02
The organ distribution of disseminated 51 Cr-labeled tumor cells. Cancer Res (1967) 1.01
Glycogen-rich, clear cell breast cancer: with comments concerning other clear cell variants. Hum Pathol (1985) 0.99
The ceroid nature of the so-called "Hamazaki-Wesenberg bodies". Am J Clin Pathol (1973) 0.99
Electron microscopic study of dermal capillaries in diabetes mellitus. Lab Invest (1966) 0.99
Evaluation of mammography based upon correlation of specimen mammograms and histopathologic findings. Am J Clin Pathol (1974) 0.98
Ultrastructural studies in hypertension. I. Comparison of renal vascular and juxtaglomerular cell alterations in essential and renal hypertension in man. Lab Invest (1966) 0.98
Lobular carcinoma of the breast: an overview. Ann Surg (1977) 0.97
Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. AJR Am J Roentgenol (1998) 0.97
Comparative ultrastructural study of so-called renal adenoma and carcinoma. J Urol (1972) 0.96
Comparative histopathologic, histochemical, electron microscopic and tissue culture studies of bronchial carcinoids and oat cell carcinomas of lung. Am J Clin Pathol (1978) 0.96
Experimental evaluation of liver atrophy and portacaval shunt. Surg Gynecol Obstet (1967) 0.96
Thyroid and parathyroid implantation: an experimental re-evaluation. Surgery (1967) 0.95
Studies concerning the regional lymph node in cancer. I. Initiation of immunity. Cancer (1971) 0.94
Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. NCI Monogr (1986) 0.94
Relationship of pathologic and some clinical discriminants to the spread of breast cancer. Int J Radiat Oncol Biol Phys (1977) 0.94
The intestine as a source of a portal blood factor responsible for liver regeneration. Surg Gynecol Obstet (1973) 0.94
A nonencapsulated sclerosing lesion of the breast. Am J Clin Pathol (1979) 0.94
Barrier function of lymph node to tumor cells and erythrocytes. II. Effect of x-ray, inflammation, sensitization and tumor growth. Cancer (1967) 0.94
Ultrastructural studies in hypertension. II. Renal vascular changes in progressive systemic sclerosis. Lab Invest (1966) 0.93
Analysis of histopathologic and electron microscopic determinants of keratoacnthoma and squamous cell carcinoma. Cancer (1972) 0.93
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure. Cancer (1980) 0.92
Ultrastructural renal changes in juvenile diabetics. JAMA (1967) 0.92
Primary reticulum cell sarcoma (microglioma) of brain. An electron microscopic study. Arch Pathol (1969) 0.92
Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors. Cancer (1975) 0.92
Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations. World J Surg (1985) 0.92
Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells. Cancer (1974) 0.91
Effect of antilymphocyte serum on parameters of growth of MCA-induced tumours. Nature (1969) 0.91
Ultrastructural observations of skeletal muscle in myopathy and neuropathy with special reference to muscular dystrophy. Lab Invest (1966) 0.90
The histopathology of mammographic patterns. Am J Clin Pathol (1978) 0.89
Lysosomal nature of juxtaglomerular granules. Science (1966) 0.89
Prognostic and therapeutic significance of pathological features of breast cancer. NCI Monogr (1986) 0.89